News Coverage - Parker Institute for Cancer Immunotherapy

Research
Network
News
About
Donate

Research
Network
- Research Institutions
  Our academic collaborators’ seminal contributions push the field forward
- Directory
  Our constellation of renowned thinkers and partners
- Strategic Partnerships
  The right collaborators across pharma, biotech and nonprofit
- Early Career Researcher Awards
  The next generation of scientific leaders in cancer immunotherapy
News
- News Menu
  - The Latest
    Stories & Announcements
  - News Coverage
    PICI in the News
  - Podcast
    From Bench to Fireside
  - For Media
    Resources for Press
About
- Mission & Vision
  Develop breakthrough immune therapies to turn all cancers into curable diseases faster
- Leadership & Staff
  The driving force behind PICI’s research and operations
- Careers
  Join us. Change lives.
Donate

BioCentury

10.17.19

Parker Institute’s ArsenalBio launches with $85M to build cell engineering war chest

Read

STAT News

10.17.19

Sean Parker, billionaire and philanthropist, gets an immunotherapy company off the ground

Read

San Fernando Valley Business Journal

10.17.19

Westlake Village BioPartners Takes Stake in Cancer Therapy Startup

Read

FierceBiotech

10.17.19

ArsenalBio joins next-gen cell therapy field with $85M A round

Read

FinSMEs

10.17.19

ArsenalBio Raises $85M in Series A Financing

Read

TIME

10.17.19

Al Gore on Impeachment, Adam Silver on China and Selma Blair on Her MS Diagnosis: Here Are Biggest Moments From the TIME 100 Health Summit

Read

BioSpace

10.17.19

ArsenalBio Launches with $28 Million Series A to Develop Next-Generation Immunotherapies

Read

Inside Philanthropy

10.15.19

Who Are America’s Most—and Least—Generous Young Billionaires

Read

TIME

10.10.19

New Speakers Announced for the First-Ever TIME 100 Health Summit on October 17 in New York, NY

Read

Precision Medicine World Conference

09.23.19

An Interview with Theresa LaVallee, Parker Institute for Cancer Immunotherapy

Read

TIME

09.20.19

TIME 100 Health Summit

Read

GenomeWeb

09.19.19

Celsius Therapeutics to Use Single-Cell Platform in Three New Immuno-Oncology Collaborations

Read